SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: alexander orlov who wrote (2770)5/22/1998 4:55:00 PM
From: Anthony Wong  Respond to of 9523
 
Alexander, I remember that well. I used to own WLA, sold at $148 and hadn't bought back at $110. Been regretting that ever since.



To: alexander orlov who wrote (2770)5/22/1998 4:56:00 PM
From: Anthony Wong  Respond to of 9523
 
Pfizer Inc. Reiterated 'Strong Buy' at Gruntal

Bloomberg News
May 22, 1998, 12:37 p.m. PT

Princeton, New Jersey, May 22 (Bloomberg) -- Pfizer Inc. (PFE US)
was reiterated ''strong buy'' by analyst David Saks at Gruntal & Co.
The 12-month target price is $136.00 per share.

-- Sybil Carlson in the Princeton, New Jersey newsroom, (609)279-3615



To: alexander orlov who wrote (2770)5/23/1998 7:25:00 PM
From: Lazlo Pierce  Respond to of 9523
 
Alexander, one of the differences between WLA and PFE is the stocks P/E. PFE is selling for a much higher P/E and even the perception that there MAY be a problem is enough to shake out many. If unfounded it will return.

Dave


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News